Articles

Videos

Podcasts

Clinical Role

Ependymoma is a rare type of tumor that develops in the brain or spinal cord and can occur at any age, but occurs most frequently in young children.


FDA Grants Rare Pediatric Disease Designation to Treatment for Ependymoma

Oral chemotherapies can be effective treatments for children with low-grade gliomas, although clinicians should consider available formulations and administration schedules. 

Expert: Consider Oral Chemotherapies for Pediatric Patients With Low-Grade Gliomas

Home infusion within the larger ambulatory infusion setting poses some specific advantages and disadvantages in relation to the other location options available.

Assessing the Advantages, Disadvantages of Intravenous Cancer Therapies in the Home 

In each trial, overall response rate and median progression-free survival in the novel treatment arm showed significant improvement over the sunitinib treatment arm in patients with renal cell carcinoma. 

Study: Four Treatment Options for Renal Cell Carcinoma Prove More Effective Than Sunitinib Monotherapy

Lakesha M. Butler, PharmD, BCPS, diversity and inclusion coordinator and clinical professor at Southern Illinois University Edwardsville, discussed causes of health inequity and how pharmacists can prevent and mitigate them to improve patient outcomes.

HOPA Keynote Speaker Addresses Structural Racism in Pharmacy

A drug recycling program can help increase patient access and minimize waste of expensive oral cancer medications.

Impact of a Drug Repository Program in a Rural Oncology Clinic

Promising investigational oncology drugs include oral taxanes, small molecule drugs, and immunotherapies. 

Oncology Investigational Drug Developments Remain Promising, Despite Impact of COVID-19 Pandemic on Clinical Trials

Common factors that contributed to reported increased dissatisfaction at work include role conflict, quantity of work, workflow disruptions, organizational culture, and leadership support.

Hematology/Oncology Pharmacists Report Experiencing High Levels of Burnout

Even while therapeutically anticoagulated, patients with cancer have risk factors for recurring venous thromboembolism and bleeding, according to a session at the Hematology/Oncology Pharmacy Association 2021 Virtual Annual Conference. 

Prophylactic Approach to Cancer-Related Thrombosis May Be Optimal

Sacituzumab govitecan (Trodelvy) approved for patients with locally advanced or metastatic urothelial cancer who previously received a platinum-containing chemotherapy and either a PD-1 or PD-L1 inhibitor.